GlassScriptPhysician profile
John Kevin Heifner
NPI 1588666895
$45,264.04
in general payments reported to CMS, 2019-2025
14 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $1,866 · 2021: $34.03 · 2022: $79.22 · 2023: $43K · 2024: $125 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Travel and Lodging: $15K · Food and Beverage: $4,508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $23,799.08 |
| Travel and Lodging | $14,803.45 |
| Food and Beverage | $4,507.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $42,691.60 | 2023 | Geminus, Align, Ijs |
| Horizon Therapeutics Plc | $1,809.75 | 2019-2021 | |
| Fresenius USA Marketing, INC. | $210.34 | 2022-2025 | Velphoro, Velphoro |
| Otsuka America Pharmaceutical, INC. | $125.14 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $115.12 | 2020-2025 | Farxiga |
| Vifor Pharma, INC. | $60.99 | 2024-2025 | Veltassa |
| Stryker Corporation | $56.22 | 2020 | |
| Nxstage Medical, INC. | $39.62 | 2025 | |
| Amgen INC. | $35.41 | 2019-2024 | Krystexxa |
| Travere Therapeutics, INC. | $35.28 | 2023-2025 | Filspari |
| Calliditas Therapeutics US INC. | $27.20 | 2023 | Tarpeyo |
| Bayer Healthcare Pharmaceuticals INC. | $23.31 | 2025 | |
| Akebia Therapeutics INC | $19.07 | 2019 | |
| Pfizer INC. | $14.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Heifner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.